Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brad H Nelson

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Oncoimmunology|August 8, 2014
Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8<sup>+</sup> tumor-infiltrating lymphocytes in ovarian cancerJohn R Webb, Katy Milne, Brad H Nelson
Cancer Immunology Research|May 10, 2015
PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian CancerJohn R Webb, Katy Milne, Brad H Nelson
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferationHeather M Lockyer, Eric Tran, Brad H Nelson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian CancerDavid R Kroeger, Katy Milne, Brad H Nelson
Nature Reviews. Immunology|May 5, 2022
Tumour immunotherapy: lessons from predator-prey theoryPhineas T Hamilton, Bradley R Anholt, Brad H Nelson
Bioinformatics (Oxford, England)|January 13, 2009
Profiling model T-cell metagenomes with short readsRené L Warren, Brad H Nelson, Robert A Holt
Gynecologic Oncology|March 15, 2016
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancerJohn R Webb, Katy Milne, David R Kroeger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell deathLaurence E Cheng, Claes Ohlén, Brad H Nelson, et al.
Vaccine|December 1, 2010
Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C)Darin A Wick, Spencer D Martin, Brad H Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2012
The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literatureRonald J deLeeuw, Sara E Kost, Juzer A Kakal, et al.
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Oncoimmunology|August 8, 2014
Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8<sup>+</sup> tumor-infiltrating lymphocytes in ovarian cancerJohn R Webb, Katy Milne, Brad H Nelson
Cancer Immunology Research|May 10, 2015
PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian CancerJohn R Webb, Katy Milne, Brad H Nelson
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferationHeather M Lockyer, Eric Tran, Brad H Nelson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian CancerDavid R Kroeger, Katy Milne, Brad H Nelson
Nature Reviews. Immunology|May 5, 2022
Tumour immunotherapy: lessons from predator-prey theoryPhineas T Hamilton, Bradley R Anholt, Brad H Nelson
Bioinformatics (Oxford, England)|January 13, 2009
Profiling model T-cell metagenomes with short readsRené L Warren, Brad H Nelson, Robert A Holt
Gynecologic Oncology|March 15, 2016
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancerJohn R Webb, Katy Milne, David R Kroeger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell deathLaurence E Cheng, Claes Ohlén, Brad H Nelson, et al.
Vaccine|December 1, 2010
Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C)Darin A Wick, Spencer D Martin, Brad H Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2012
The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literatureRonald J deLeeuw, Sara E Kost, Juzer A Kakal, et al.
Pageof 14